PT96994A - Metodo para purificacao de hiv gp12o, de forma a proporcionar um glicopeptido - Google Patents

Metodo para purificacao de hiv gp12o, de forma a proporcionar um glicopeptido

Info

Publication number
PT96994A
PT96994A PT96994A PT9699491A PT96994A PT 96994 A PT96994 A PT 96994A PT 96994 A PT96994 A PT 96994A PT 9699491 A PT9699491 A PT 9699491A PT 96994 A PT96994 A PT 96994A
Authority
PT
Portugal
Prior art keywords
protein
hiv
binding affinity
glycopeptide
substantially identical
Prior art date
Application number
PT96994A
Other languages
English (en)
Other versions
PT96994B (pt
Inventor
Nancy L Haighwood
Carl Scandella
Original Assignee
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23949786&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT96994(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp filed Critical Chiron Corp
Publication of PT96994A publication Critical patent/PT96994A/pt
Publication of PT96994B publication Critical patent/PT96994B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Table Devices Or Equipment (AREA)
  • Cookers (AREA)
  • Gloves (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT96994A 1990-03-09 1991-03-08 Metodo para purificacao da gp12o de hiv, de forma a proporcionar um glicopeptido PT96994B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49085890A 1990-03-09 1990-03-09

Publications (2)

Publication Number Publication Date
PT96994A true PT96994A (pt) 1991-10-31
PT96994B PT96994B (pt) 1998-07-31

Family

ID=23949786

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96994A PT96994B (pt) 1990-03-09 1991-03-08 Metodo para purificacao da gp12o de hiv, de forma a proporcionar um glicopeptido

Country Status (8)

Country Link
EP (1) EP0519001B2 (pt)
JP (2) JP2624894B2 (pt)
AT (1) ATE207930T1 (pt)
CA (1) CA2077753C (pt)
DE (1) DE69132795T3 (pt)
IE (1) IE910779A1 (pt)
PT (1) PT96994B (pt)
WO (1) WO1991013906A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE207930T1 (de) * 1990-03-09 2001-11-15 Chiron Corp Gereinigtes gp120, in dem seine natürliche konformation erhalten bleibt
EP0527760B1 (en) * 1990-04-03 1995-07-19 Genentech, Inc. Methods and compositions for vaccination against hiv
US7041293B1 (en) 1990-04-03 2006-05-09 Genentech, Inc. HIV env antibodies
DK0679187T4 (da) † 1993-01-16 2001-09-17 Manfred Schawaller Fremgangsmåde til udvinding af native, oligomere, glycosylerede ektodomæner fra virale membranproteiner, og deres anvendelse, især som vaccine mod HIV
EP0708659A4 (en) 1993-06-07 2000-08-23 Genentech Inc HIV ENVELOPE POLYPEPTIDE
JP3313117B2 (ja) * 1994-03-22 2002-08-12 ザ イミューン リスポンス コーポレイション ウイルス粒子の効率の高い生産および単離
KR100374308B1 (ko) * 1995-07-27 2003-12-18 주식회사 엘지생명과학 재조합차이니스햄스터오바리세포로부터발현된수두바이러스의지피i당단백질의정제방법
US6585979B1 (en) 1996-07-08 2003-07-01 Genentech, Inc. HIV envelope polypeptides and immunogenic composition
ES2299276T3 (es) 1998-12-31 2008-05-16 Novartis Vaccines And Diagnostics, Inc. Polipeptidos env del vih modificados.
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
CA2634992C (en) 2001-07-05 2012-10-16 Novartis Vaccines And Diagnostics, Inc. Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
US7786288B2 (en) * 2003-10-23 2010-08-31 Karp Nelson M Immunizing compositions encoding an epitope obtained from the HIV-1 capsid protein cyclophilin A binding site
JPWO2006011580A1 (ja) * 2004-07-27 2008-05-01 ジェノミディア株式会社 ウイルスエンベロープの精製方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01120284A (ja) * 1987-11-05 1989-05-12 Shiro Kato Ｈｉｖ不完全粒子および該製造方法
ATE207930T1 (de) * 1990-03-09 2001-11-15 Chiron Corp Gereinigtes gp120, in dem seine natürliche konformation erhalten bleibt

Also Published As

Publication number Publication date
JP2624894B2 (ja) 1997-06-25
EP0519001B2 (en) 2007-12-19
CA2077753A1 (en) 1991-09-10
EP0519001A1 (en) 1992-12-23
WO1991013906A1 (en) 1991-09-19
DE69132795D1 (de) 2001-12-13
DE69132795T2 (de) 2002-06-20
EP0519001B1 (en) 2001-10-31
CA2077753C (en) 2000-02-29
PT96994B (pt) 1998-07-31
IE910779A1 (en) 1991-09-11
JPH09227588A (ja) 1997-09-02
DE69132795T3 (de) 2008-07-10
JPH05505616A (ja) 1993-08-19
ATE207930T1 (de) 2001-11-15

Similar Documents

Publication Publication Date Title
PT96994A (pt) Metodo para purificacao de hiv gp12o, de forma a proporcionar um glicopeptido
Furthmayr et al. Fractionation of the major sialoglycopeptides of the human red blood cell membrane
DK0458841T3 (da) Fremgangsmåde til anvendelse og fremstilling af peptider
MX9603637A (es) Purificacion de anticuerpo.
ES2146600T3 (es) Condroitinasa, procedimiento para su preparacion y composicion farmaceutica.
ES2188665T3 (es) Procedimiento para la preparacion de fragmentos de cardiodilatina, fragmentos de cardiodilatina muy purificados y productos intermedios para su preparacion.
PL374311A1 (en) Methods for purifying protein
DK0731812T3 (da) Fremgangsmåde til isolering af Poly-beta-1-4-N-Acetylglucosamin
SE8402861D0 (sv) Rening av biologiskt material
CA1133898A (en) Purification of interferon
ES2058538T3 (es) Compuestos de proteina a purificados y procedimiento para su preparacion.
PT98669A (pt) Processo para a preparacao da estrutura proteica da toxina de gelonina vegetal
JP2004512539A (ja) 複合分離法
Zlotkin et al. A protein toxic to crustacea from the venom of the scorpion Androctonus australis
DK0402205T3 (da) Fremgangsmåde til fremstilling af oprensede albuminopløsninger
EP0239311A3 (en) Mutual separation of proteins
EP0252064A3 (en) Preparations active against pseudomonas aeruginosa infections, and process for their preparation
CA2369827A1 (en) Separation of plasma components
EP0117470B1 (en) Process for producing interferon (ifn-gamma) subtypes 26k and 21k
Kobayashi et al. Improved procedure for the isolation of J-chain from human polymeric immunoglobulins
CA1270597A (en) Thf compositions
Polo et al. HPLC purification of the main allergen of Parietaria judaica pollen
DE3686961D1 (de) Polydisperse native pseudomonas-flagella(h)-antigene (fag) und verfahren zu ihrer gewinnung.
Ishaq et al. Purification and identification of antigenic polypeptides of Sm and RNP antigens of goat liver
TH17361A (th) โปรตีนจากรีคอมบิแนนท์ มิวแทนท์ ของpasteurella multocida กรรมวิธีสำหรับเตรียมลำดับดีเอนเอที่มีประมวลรหัสของโปรตีนเรพลิคอนที่มีลำดับดีเอนเอและเซลล์ที่ทรานสฟอร์มด้วยเรพลิคอนดังกล่าวชนิดเดียวกัน

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910710

FG3A Patent granted, date of granting

Effective date: 19980414

PD4A Change of proprietorship

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC., US

Effective date: 20080215

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20130415